1,311 results on '"Stefan, Norbert"'
Search Results
2. Effect of essential phospholipids on hepatic steatosis in metabolic dysfunction-associated steatotic liver disease associated with type 2 diabetes mellitus and/or hyperlipidemia and/or obesity: study protocol of a randomized, double-blind, phase IV clinical trial
3. Obesity and Type 2 Diabetes
4. Second international consensus report on gaps and opportunities for the clinical translation of precision diabetes medicine
5. Automated shape-independent assessment of the spatial distribution of proton density fat fraction in vertebral bone marrow
6. Role of steatotic liver disease in prediction and prevention of cardiometabolic diseases
7. Metabolic dysfunction-associated steatotic liver disease and extrahepatic gastrointestinal cancers
8. Precision subclassification of type 2 diabetes: a systematic review
9. Diabetes und Fettleber
10. Comparison of the accuracy of commercial two-point and multi-echo Dixon MRI for quantification of fat in liver, paravertebral muscles, and vertebral bone marrow
11. Analysis of type 2 diabetes heterogeneity with a tree-like representation: insights from the prospective German Diabetes Study and the LURIC cohort
12. Prädiabetes – eine Krankheit?
13. Mechanisms of weight loss-induced remission in people with prediabetes: a post-hoc analysis of the randomised, controlled, multicentre Prediabetes Lifestyle Intervention Study (PLIS)
14. A global research priority agenda to advance public health responses to fatty liver disease
15. Metabolic health and cardiometabolic risk clusters: implications for prediction, prevention, and treatment
16. Glucagon und Katecholamine – Gegenspieler des Insulins
17. Insulin – das wichtigste anabole Hormon
18. The role of hepatokines in NAFLD
19. Diabetes und Fettleber
20. A global view of the interplay between non-alcoholic fatty liver disease and diabetes
21. Fetuin-A and risk of diabetes-related vascular complications: a prospective study
22. SARS-CoV-2 fires up inflammation in adipose tissue
23. Diabetes and Fatty Liver
24. Researchers call for more flexible editorial conduct rather than abruptly adopting only the new MASLD nomenclature
25. Hemostatic alterations linked to body fat distribution, fatty liver, and insulin resistance
26. Liver-targeting drugs and their effect on blood glucose and hepatic lipids
27. Determinants of hepatic insulin clearance – Results from a Mendelian Randomization study
28. 11 Nichtalkoholische Lebererkrankungen
29. The hepatokine fetuin-A disrupts functional maturation of pancreatic beta cells
30. Diabetes und Fettleber
31. Genome-Wide Association Study of the Modified Stumvoll Insulin Sensitivity Index Identifies BCL2 and FAM19A2 as Novel Insulin Sensitivity Loci
32. Pathophysiology-based subphenotyping of individuals at elevated risk for type 2 diabetes
33. Global pandemics interconnected — obesity, impaired metabolic health and COVID-19
34. Causes, consequences, and treatment of metabolically unhealthy fat distribution
35. Role of steatotic liver disease in prediction and prevention of cardiometabolic diseases
36. Analysis of type 2 diabetes heterogeneity with a tree-like representation: insights from the prospective German Diabetes Study and the LURIC cohort
37. SGLT2 inhibition in addition to lifestyle intervention and risk for complications in subtypes of patients with prediabetes - a randomized, placebo controlled, multi-center trial (LIFETIME) – rationale, methodology and design
38. Diabetes und Fettleber
39. Elevated circulating follistatin associates with an increased risk of type 2 diabetes
40. Free fatty acids, glicentin and glucose-dependent insulinotropic polypeptide as potential major determinants of fasting substrate oxidation
41. Fettleber und Diabetes: Pathomechanismen
42. Neue arzneitherapeutische Optionen bei nichtalkoholischer Fettlebererkrankung
43. Diabetes und Fettleber
44. Associations of short stature and components of height with incidence of type 2 diabetes: mediating effects of cardiometabolic risk factors
45. Metabolic disorders, COVID-19 and vaccine-breakthrough infections
46. Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies
47. Genetic variation in TCF7L2 rs7903146 and history of GDM negatively and independently impact on diabetes-associated metabolic traits
48. Achieving replicable subphenotypes of adult-onset diabetes – Authors' reply
49. Extracellular Matrix Expression in Human Pancreatic Fat Cells of Patients with Normal Glucose Regulation, Prediabetes and Type 2 Diabetes
50. Transition from metabolic healthy to unhealthy phenotypes and association with cardiovascular disease risk across BMI categories in 90 257 women (the Nurses' Health Study): 30 year follow-up from a prospective cohort study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.